SensArs develops a neuroprosthetic system that utilizes intra-nerve electrode arrays to restore sensory feedback in individuals with limb loss or diabetic neuropathy. This technology addresses the disruption of nerve signals, significantly reducing the risk of complications such as falls and ulcers.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with limb loss or diabetic neuropathy often experience a disruption of nerve signals, leading to a loss of protective sensations. This sensory deprivation significantly increases the risk of complications such as falls, ulcers, and ultimately, amputation. Current solutions do not address the core issue of restoring the disrupted sensory feedback loop.
Solution
SensArs is developing a neuroprosthetic system designed to restore sensory feedback in individuals with limb loss or diabetic neuropathy. The system utilizes intra-nerve electrode arrays to stimulate the peripheral nervous system, reviving communication between nerve-damaged areas and the brain. By implanting an electrode array inside the peripheral nerve, the technology accesses sensory fibers to reconstruct healthy nerve signals. Wearable sensors on the foot detect touch and movement, transmitting this information wirelessly to the implanted electrodes. This closed-loop system aims to restore protective foot sensations, thereby reducing the risk of falls, ulcers, and amputation.
Target Audience
The primary target audience includes individuals with limb loss or diabetic neuropathy who have experienced a loss of protective sensations and are at risk of developing complications such as falls and ulcers.
Features
- Intra-nerve electrode array implanted inside the peripheral nerve to access sensory fibers.
- Wearable sensors that detect touch and movement from the foot.
- Wireless transmission of sensory information from the sensors to the implanted electrodes.
- Closed-loop system designed to restore protective foot sensations.
- Technology designed to reduce the risk of falls, ulcers, and amputation in patients with sensory loss.